2022 Sepsis Symposium

Thursday, September 15, 2022, 8:30 AM - 2:30 PM, Online


AMA PRA Category 1 Credits™ (4.00 hours), ACPE Contact Hour(s) (4.00 hours), ANCC Contact Hour(s) (4.00 hours), General Attendance (4.00 hours), Non-Physician Attendance (4.00 hours), PA Patient Safety and Risk Credit (4.00 hours)

Sepsis continues to be one of the biggest risks to patient safety in hospitals, skilled nursing and other medical facilities. As new studies continue to highlight the importance of proper sepsis care, it’s critical that clinicians have access to the most up-to-date information. This activity will provide clinicians with an analysis of the Surviving Sepsis Guidelines 2021 revisions and the science behind these evidence-based recommendations. Speakers will also address the current CMS guidelines and how they are applied in sepsis care. Session will explore sepsis in different populations, addressing the unique diagnostic and management challenges. Additional sessions will include why equity matters in sepsis care, the challenges in the evaluation and management of the undifferentiated febrile patient in the ED, the role of peripheral pressors in sepsis management, and a panel of nurse leaders addressing the nurse’s role in early detection and management of sepsis. Additional session will include a Sepsis Survivor and discussion on quality of life post acute care discharge.

1. Use current evidence based strategies for decision making and care planning to reduce readmissions and improve functional status and quality of life for patients with sepsis.
2. Apply recommendations from the Surviving Sepsis Campaign 2021 revisions to align clinical decision and management of sepsis for optimal patient outcomes.
3. Debate controversial perspectives on SEP-1 based on recent publications and data.
4. Discuss factors that that impact a prompt and accurate diagnosis in the Emergency Department.
5. Discuss variabilities in presentation, management, and outcomes in the obstetric, oncologic, and post-operative patients with sepsis.
6. Assess the impact of poverty, multimorbidity, and healthcare access and quality on an individual’s risk for developing or dying from sepsis.
7. Differentiate the complaint of fever in the Emergency Department.
8. Evaluate practice guidelines and indications for use of peripheral vasopressors in sepsis management.

Registration Type	Fee
Jefferson/Mainline/Bayada employees	Free
All other healthcare providers	$50

All registrants must have an account to register for the activity.

Jefferson employees: Free registration will display after login. You must use your Jefferson email to log in.
Mainline Health employees: To receive the discount code for the free registration,  email OCPD ([email protected]). Please make the subject line Sepsis 2022-Mainline Health Discount Code.

 

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 


Physicians: This educational activity is designated for a maximum of 4.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 4.00 nursing contact hours.

Physicians Assistants:



Thomas Jefferson University has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Other Healthcare Professionals: This educational activity is designated for 4.00 AMA PRA Category 1 Credits^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Respiratory Care Education (CRCE) Credit

This course has been approved for a maximum of 4.00 contact hour(s) Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063 Course # 188112000.

Other Credit
PA Patient Safety and Risk Credit
The educational activity offers 1.0 PA Patient Safety and Risk Credit. The following sessions qualify: Understanding and Improving Health Inequities in Sepsis Care and Evaluation of Fever in the Emergency Department.

Cancellation Policy

Requests for refunds must be submitted in writing and received in the Office of CPD two weeks prior to the start date of the course. There will be no refunds after this period.*  Cancellations notified before the two week time frame will incur a 25% administration fee (with a minimum of $20).  Registrants who fail to attend the conference are responsible for the entire fee.  All refunds will be processed after the conference.  The University reserves the right to cancel or postpone this course due to unforeseen circumstances.  In the event of cancellation or postponement, the University will refund registration fees, but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines or travel agencies. 

Submit refund requests to:

Office of CPD
Sidney Kimmel Medical College
Jefferson Alumni Hall
1020 Locust Street, Suite M-5
Philadelphia, PA 19107

Or by email to [email protected] - please include the activity name in the subject line.

*Registration fees will be refunded less a 15% administration fee to international conference registrants who are unable to secure a travel visa. Registrants must provide proof of visa denial. 

Jefferson Release Policy
Jefferson may record/livestream/photograph this activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive any right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy
As an attendee of this conference hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively “Jefferson”), you may gain access to certain proprietary information (“Confidential Information”), including Protected Health Information (“PHI”).

By participating in this activity, you agree to maintain the confidentiality of all Confidential Information, including PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the activity. Further, you agree not to take photographs, record in any manner, or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Thursday, September 15, 2022

This educational activity received no commercial or in-kind support.

This educational activity is supported by an unrestricted educational grant by Mountain Laurel Risk Retention Group.